277
Views
0
CrossRef citations to date
0
Altmetric
News & Views

Institutional Profile: University of Florida and Shands Hospital Personalized Medicine Program: Clinical Implementation of Pharmacogenetics

, , , , &
Pages 723-726 | Published online: 08 May 2013

References

  • Johnson JA , BurkleyBM, LangaeeTY, Clare-SalzlerMJ, KleinTE, AltmanRB. Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array. Clin. Pharmacol. Ther.92(4) , 437–439 (2012).
  • Scott SA , SangkuhlK, GardnerEE et al. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy. Clin. Pharmacol. Ther. 90(2) , 328–332 (2011).
  • Crews KR , GaedigkA, DunnenbergerHM et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Clin. Pharmacol. Ther. 91(2) , 321–326 (2012).
  • Johnson JA , GongL, Whirl-CarrilloM et al. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin. Pharmacol. Ther. 90(4) , 625–629 (2011).
  • Relling MV , GardnerEE, SandbornWJ et al. Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin. Pharmacol. Ther. 89(3) , 387–391 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.